Alzheimers & Dementia

Papers
(The H4-Index of Alzheimers & Dementia is 61. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Issue Information2238
Cis p‐tau underlies vascular contribution to cognitive impairment and dementia, but is effectively targeted by immunotherapy1732
999
RBFOX1 is regulated by the adenosine 2a receptor and is ubiquitinated in tau tangles in Alzheimer’s disease912
558
Melatonin, metformin, and ranolazine equally improved cognitive function in rats with doxorubicin‐induced chemobrain394
High‐fat diet reduced dendritic spine density, but it did not affect cognitive function in spontaneous diabetic torii rats298
Prevalence of neuropsychiatric conditions and cognitive impairment in two parallel, aging study cohorts from rural and urban India293
265
Reframing motherhood in dementia research: A call for action185
182
Cerebrospinal fluid biomarkers in the Longitudinal Early‐onset Alzheimer's Disease Study174
Putting participants and study partners FIRST when clinical trials end early171
Entorhinal vessel density correlates with phosphorylated tau and TDP‐43 pathology168
Potential role of blood pressure variability and plasma neurofilament light in the mechanism of comorbidity between Alzheimer's disease and cerebral small vessel disease167
Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR study163
Dementias Platform UK: Bringing genetics into life151
Mendelian randomization highlights causal association between genetically increased C‐reactive protein levels and reduced Alzheimer's disease risk150
Subjective cognitive decline across ethnoracial groups in the A4 study145
A brain atlas of astrocyte transcriptomics unveils complex states and responses to Alzheimer’s disease neuropathology144
Amyloid‐Beta PET Synthesis from Structural MRI: A Potential Alternative Method for Alzheimer’s Disease Screening135
Weight loss and risk of dementia in individuals with versus without obesity133
Issue Information127
Combining high‐resolution ex vivo MRI and histopathology to identify medial temporal lobe atrophy patterns specific to tau pathology in Alzheimer’s Disease125
2021 Annual Report of Japanese Brain Bank Network for Neuroscience Research121
Ethnic Disparities in Clinical Presentation of Patients with Early‐Onset Alzheimer’s Disease121
The relationship between cortical grey to white matter signal contrast (GWC) and tau pathology in atypical AD120
Characterising the covariance pattern between lifestyle factors and structural brain measures: a multivariable study of two cohorts of older adults111
Exploring Social Engagement in a Virtual Participatory Culinary Nutrition Education Intervention for Dementia Prevention105
In Vivo Head‐To‐Head Comparison of [18F]GTP1 and [18F]PI2620 in Alzheimer’s Disease104
Prevalence of Alzheimer’s disease (AD) dementia and mild cognitive impairment (MCI) in the United States Medicare population100
Plasma biomarkers, memory impairment, and imaging measures of Alzheimer’s disease in American Indians98
Reducing Risk of ADRDs: Innovative Framework to Inform Behavior Change96
Plasma phosphorylated tau 181 and modifiable risk factors for dementia in a large scale cohort of Australian older adults93
Characterizing amyloid positive individuals with normal tau PET levels five years later: An ADNI study86
Brain‐Penetrable Antibody Probes for in vivo Tau Imaging85
The association of gait velocity and cognitive performance in a sample of older Chinese Americans: A pilot study84
Is QEEG an effective biomarker in predicting cognitive decline?84
Racial disparities in Alzheimer’s Disease (AD): Correlating a novel neuropsychological screening test to established AD fluid and imaging biomarkers in African Americans and Caucasians78
Prediction of amyloid‐beta accumulating normal cognitive elderly77
Prevalence and pathological correlates of unawareness of memory impairment in non‐demented individuals with autosomal dominant Alzheimer’s disease: an item‐level investigation of the Memory Complaints76
Understanding differences in antidepressant use patterns among african american and white volunteers with dementia76
Quantitative amyloid PET in the AMYPAD diagnostic and patient management study75
Ancestry‐Specific eQTL Associations in AA/NHW Alzheimer Disease Cohorts74
A systematic evaluation of hippocampal GABA levels in transgenic mouse models of amyloid and tau72
The impact of the COVID‐19 pandemic on cognitive health71
Technical performance and biotemporal stability evaluation of Olink proximity extension assay for blood‐based biomarker discovery70
Depression in Alzheimer’s disease hospitalized patients: A descriptive analysis of a nationwide database68
The troubles and needs of family caregivers of older adults with moderate to severe dementia68
Transgender adults report greater cognitive and related functional challenges: Findings from the 2015‐2019 Behavioral Risk Factor Surveillance System67
Hyperintensity on Diffusion‐Weighted MRI and Clinical Correlations in Probable Creutzfeldt‐Jakob Disease66
CSF amyloid, tau, and neurodegeneration biomarkers are associated with longitudinal cognitive decline in preclinical AD66
Increased regional brain inflammation predicts longitudinal brain atrophy in individuals in the Alzheimer’s disease continuum65
Associations of sleep disturbances with cognitive function and plasma Alzheimer’s biomarkers in Chinese rural‐dwelling older adults: A population‐based study64
Rural/Urban Disparities in PQIs Among Patients with ADRD – Evidence of Hospital‐based HIT and Enabling Services63
Investigation of sex differences in mutation carriers of the Dominantly Inherited Alzheimer Network63
From identification to implementation: state of the art in biomarkers for immune function in CSF and blood62
Testamentary Capacity Assessment Tool (TCAT): An update report62
Association of Epigenetic Aging with Cognitive Aging in Diverse Hispanics/Latinos62
Explainable AI and its instantiation in Computational Pathology for a better understanding of Alzheimer’s disease61
Association of anticholinergic medication and AD biomarkers among cognitively normal late middle‐age adults: Results from the Wisconsin Registry for Alzheimer's Prevention (WRAP)61
Impaired retinal capillary function in patients with clinical Alzheimer’s disease61
0.1827380657196